Tarsus Xdemvy Secures FDA's Approval

Tarsus Xdemvy Secures FDA’s Approval

Tarsus Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) approved Xdemvy (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis.…

Read More »